SPDR® S&P Pharmaceuticals ETF
Portfolio
Holdings
Symbol | Name | Country | Sector | Industry | Most recent quarter | % of Total Shares | % of Total Assets | Shares | Book Value | Market Price Value | Fundamental Score | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ACRS.NASDAQ | Aclaris Therapeutics Inc | USA | Healthcare | Diagnostics & Research | 2024-09-30 | 0.304 | 0.813 | 214.5k | $260.8k | $551.2k |
| |||||||||||||
AMLX.NASDAQ | Amylyx Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.443 | 0.872 | 981.2k | $2.8m | $3.5m |
| |||||||||||||
AXSM.NASDAQ | Axsome Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.271 | 4.379 | 128k | $245.4k | $11.7m |
| |||||||||||||
CRMD.NASDAQ | CorMedix Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.413 | 1.242 | 250.8k | $242.8k | $3m |
| |||||||||||||
EOLS.NASDAQ | Evolus Inc | USA | Healthcare | Drug Manufacturers - Specialty & Generic | 2024-09-30 | 0.278 | 1.189 | 176.1k | $16.3k | $1.8m |
| |||||||||||||
ESPR.NASDAQ | Esperion Therapeutics Inc | USA | Healthcare | Drug Manufacturers - Specialty & Generic | 2024-09-30 | 0.318 | 0.842 | 625.6k | -$1.1m | $1.3m |
| |||||||||||||
FULC.NASDAQ | Fulcrum Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.81 | 1.072 | 436.7k | $1.8m | $1.7m |
| |||||||||||||
HROW.NASDAQ | Harrow Health Inc | USA | Healthcare | Drug Manufacturers - Specialty & Generic | 2024-09-30 | 0.382 | 2.788 | 135.9k | $219.3k | $4.6m |
| |||||||||||||
INVA.NASDAQ | Innoviva Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.496 | 2.177 | 345.8k | $3.6m | $6.4m |
| |||||||||||||
LQDA.NASDAQ | Liquidia Technologies Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.236 | 1.438 | 199.9k | $261.1k | $2.5m |
| |||||||||||||
MNMD.NASDAQ | Mind Medicine Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.216 | 0.673 | 158.2k | $517k | $1.1m |
| |||||||||||||
NKTR.NASDAQ | Nektar Therapeutics | USA | Healthcare | Biotechnology | 2024-09-30 | 0.553 | 1.798 | 1m | $241k | $918.7k |
| |||||||||||||
NUVB.NYSE | Nuvation Bio Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.042 | 0.238 | 92.6k | $138.8k | $232.6k |
| |||||||||||||
OCUL.NASDAQ | Ocular Therapeutix Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.371 | 2.726 | 578.2k | $1.2m | $4.6m |
| |||||||||||||
PANA.NASDAQ | PANA.NASDAQ | - | - | - | - | 0.042 | 0.238 | 92.6k | - | - | ||||||||||||||
PRVB.NASDAQ | PRVB.NASDAQ | - | - | - | - | 0.28 | 3.393 | 265.7k | - | - | ||||||||||||||
RETA.NASDAQ | RETA.NASDAQ | - | - | - | - | 0.518 | 3.502 | 189.6k | - | - | ||||||||||||||
RLMD.NASDAQ | Relmada Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.231 | 0.151 | 69.5k | $109.7k | $26k |
| |||||||||||||
ROIV.NASDAQ | Roivant Sciences Ltd | USA | Healthcare | Biotechnology | 2024-09-30 | 0.032 | 0.356 | 221.9k | $1.6m | $2.4m |
| |||||||||||||
RVNC.NASDAQ | Revance The | USA | Healthcare | Biotechnology | 2024-09-30 | 0.689 | 1.423 | 605.2k | -$945.4k | $2.2m |
| |||||||||||||
SAVA.NASDAQ | Cassava Sciences Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.35 | 0.412 | 168.4k | $583.5k | $463.2k |
| |||||||||||||
SIGA.NASDAQ | SIGA Technologies Inc | USA | Healthcare | Drug Manufacturers - Specialty & Generic | 2024-09-30 | 0.573 | 1.311 | 413.9k | $977.2k | $2.5m |
| |||||||||||||
TARS.NASDAQ | Tarsus Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.28 | 1.767 | 104.8k | $648.5k | $4.8m |
| |||||||||||||
XERS.NASDAQ | Xeris Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.201 | 0.62 | 299.2k | -$56.8k | $957.4k |
|
Trades
Adds
Report date: 2024-12-31
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
CRMD.NASDAQ | 6.6k | 2.7 | 66k | 8-14 | $12.17 | 56.2% |
EOLS.NASDAQ | 4.6k | 2.7 | 65.3k | 11-18 | $10.51 | -0.8% |
ESPR.NASDAQ | 16.5k | 2.7 | 38.5k | 2-4 | $2.21 | 39.9% |
HROW.NASDAQ | 3.5k | 2.7 | 158.6k | 32-59 | $33.85 | 4.5% |
LQDA.NASDAQ | 5.2k | 2.7 | 57.6k | 10-12 | $12.89 | 32.7% |
MNMD.NASDAQ | 4.1k | 2.7 | 28.7k | 5-10 | $7.16 | 42.2% |
XERS.NASDAQ | 7.8k | 2.7 | 25.3k | 3-4 | $3.20 | 19.0% |
Report date: 2024-09-30
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
FULC.NASDAQ | 5.8k | 1.2 | 43.6k | 3-10 | $3.96 | 38.2% |
LQDA.NASDAQ | 2k | 1.2 | 22.5k | 8-14 | $12.89 | 56.1% |
MNMD.NASDAQ | 3.3k | 1.2 | 23.6k | 6-10 | $7.16 | 28.7% |
SAVA.NASDAQ | 2.2k | 1.2 | 52.3k | 9-42 | $2.75 | -68.9% |
XERS.NASDAQ | 3.4k | 1.2 | 8.9k | 2-3 | $3.20 | 57.6% |
Report date: 2023-11-30
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
AMLX.NASDAQ | 2.9k | 1.0 | 49.6k | 12-22 | $3.60 | -69.5% |
EOLS.NASDAQ | 1.1k | 1.0 | 10.5k | 7-10 | $10.51 | 41.3% |
HROW.NASDAQ | 1.3k | 1.0 | 17.8k | 8-17 | $33.85 | 345.4% |
OCUL.NASDAQ | 3k | 1.0 | 8.7k | 2-4 | $8.01 | 301.5% |
SAVA.NASDAQ | 2k | 1.0 | 39.5k | 12-25 | $2.75 | -77.7% |
TARS.NASDAQ | 855.00 | 1.0 | 13.7k | 13-19 | $46.52 | 270.1% |
Report date: 2023-08-31
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
SAVA.NASDAQ | 1.3k | 0.9 | 28.2k | 17-27 | $2.75 | -83.4% |
Reduces
Report date: 2024-10-31
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
FULC.NASDAQ | -5.8k | -1.5 | -35k | 3-10 | $3.96 | 38.2% |
LQDA.NASDAQ | -2k | -1.5 | -21.9k | 8-14 | $12.89 | 56.1% |
MNMD.NASDAQ | -3.3k | -1.5 | -21.3k | 5-10 | $7.16 | 42.2% |
SAVA.NASDAQ | -2.2k | -1.5 | -63.4k | 18-42 | $2.75 | -84.5% |
Report date: 2024-03-31
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
AMLX.NASDAQ | -20.4k | -2.0 | -267.4k | 3-20 | $3.60 | 34.8% |
LQDA.NASDAQ | -3.1k | -2.0 | -43.9k | 11-17 | $12.89 | 16.0% |
SAVA.NASDAQ | -3.8k | -2.0 | -88.2k | 18-27 | $2.75 | -84.9% |
TARS.NASDAQ | -2.1k | -2.0 | -61.7k | 19-40 | $46.52 | 145.0% |
XERS.NASDAQ | -8.1k | -2.0 | -21k | 2-3 | $3.20 | 60.0% |
Report date: 2023-06-22
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
AXSM.NASDAQ | -2.4k | -1.8 | -175.1k | 57-91 | $91.94 | 62.0% |
SAVA.NASDAQ | -2.5k | -1.8 | -61.6k | 21-29 | $2.75 | -87.2% |
Report date: 2023-05-31
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
ACRS.NASDAQ | -3.8k | -1.8 | -32.7k | 6-13 | $2.57 | -55.5% |
AXSM.NASDAQ | -3k | -1.8 | -205.3k | 54-83 | $91.94 | 71.2% |
ESPR.NASDAQ | -8.8k | -1.8 | -17.2k | 1-7 | $2.21 | 97.3% |
SAVA.NASDAQ | -3k | -0.9 | -74.5k | 21-29 | $2.75 | -87.2% |
Report date: 2023-02-28
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
AXSM.NASDAQ | -2.3k | -1.9 | -167.9k | 60-82 | $91.94 | 54.5% |
ESPR.NASDAQ | -6.5k | -1.9 | -41k | 5-9 | $2.21 | -54.7% |
PRVB.NASDAQ | -3.8k | -1.9 | -35.1k | 8-11 | - | - |
SAVA.NASDAQ | -4.5k | -1.9 | -145.6k | 24-45 | $2.75 | -88.6% |
SIGA.NASDAQ | -7.9k | -1.9 | -59.6k | 6-9 | $6.23 | -3.8% |
Report date: 2022-11-30
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
AXSM.NASDAQ | -1.1k | -1.0 | -63.5k | 39-80 | $91.94 | 136.5% |
EOLS.NASDAQ | -2k | -1.0 | -17.1k | 7-11 | $10.51 | 50.9% |
RETA.NASDAQ | -1.9k | -1.0 | -58.1k | 22-44 | - | - |
RLMD.NASDAQ | -699.00 | -1.0 | -13.1k | 5-39 | $0.37 | -91.7% |
SAVA.NASDAQ | -2.2k | -1.0 | -80.2k | 24-52 | $2.75 | -88.7% |
SIGA.NASDAQ | -5.3k | -1.0 | -55.1k | 8-16 | $6.23 | -24.5% |
Report date: 2022-09-30
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
AMLX.NASDAQ | -1.9k | -1.0 | -49.2k | 16-33 | $3.60 | -77.2% |
Report date: 2022-03-09
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
NUVB.NYSE | -2k | -2.2 | -13.3k | 4-10 | $2.51 | -43.7% |
PANA.NASDAQ | -2k | -2.2 | -19.8k | 10-10 | - | - |
Comments
How you think about this?